Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0TNSIO
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
ABC-3C
|
|||||
| Synonyms |
ABC 3C
Click to Show/Hide
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Escherichia coli infection [ICD11:1A03]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Antibody Name |
Targeted against E. coli mAb (hWN1)
|
Antibody Info | ||||
| Antigen Name |
Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (ERBB3)
|
Antigen Info | ||||
| Payload Name |
Macrocyclic antimicrobial peptide 3C (AMP-3C)
|
Payload Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Site-specific conjugation through the Sortase A.
|
|||||
General Information of The Activity Data Related to This ADC
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Effective Concentration (EC50) |
40.00 nM
|
|||
| Method Description |
Bacterial killing potencies and hemolytic activities of prepared ABCs. MKC 50 represents the minimal concentration to impart >50 % killing.
|
||||
| In Vitro Model | . | Escherichia coli 2 (E. coli 2) | . | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Effective Concentration (EC50) |
170 nM
|
|||
| Method Description |
Bacterial killing potencies and hemolytic activities of prepared ABCs. MKC 50 represents the minimal concentration to impart >50 % killing.
|
||||
| In Vitro Model | . | Escherichia coli 1 (E. coli 1) | . | ||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.